# Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors

> clinical trial · VERIFIED · 2026-08-12

Status: RECRUITING · Sponsor: Hanmi Pharmaceutical Company Limited · Condition: Advanced or Metastatic Solid Tumors

- Company: Hanmi Pharmaceutical Company Limited
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06234397

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.